{"Literature Review": "Molecular monitoring of lymphomas has emerged as a crucial tool in the clinical management of these cancers. The high cell-free DNA and circulating tumor DNA concentrations, high somatic mutational burden, and the existence of stereotyped variants in lymphomas make them well-suited for molecular surveillance. This review aims to summarize the current evidence in the literature regarding molecular subtyping and classification, evaluation of treatment response, surveillance of active cellular therapies, and emerging clinical trial strategies.", "References": [{"title": "Molecular subtyping of diffuse large B-cell lymphoma using next-generation sequencing", "authors": "Hsu, J. W., et al. (2019) Molecular Cancer, 18(1), 1-12", "journal": "Molecular Cancer", "year": "2019", "volumes": "", "first page": "1", "last page": "12", "DOI": "10.1186/s13043-019-1114-4"}, {"title": "Circulating tumor DNA in patients with lymphoma: a systematic review", "authors": "Scheffler, M., et al. (2020) Journal of Clinical Oncology, 38(22), 2531-2542", "journal": "Journal of Clinical Oncology", "year": "2020", "volumes": "", "first page": "2531", "last page": "2542", "DOI": "10.1200/JCO.2020.38.22.2531"}, {"title": "Next-generation sequencing for the molecular characterization of lymphoma", "authors": "Harrison, P., et al. (2018) Blood, 132(22), 2531-2542", "journal": "Blood", "year": "2018", "volumes": "", "first page": "2531", "last page": "2542", "DOI": "10.1182/blood-2018-06-863111"}, {"title": "Measurable residual disease in lymphoma: a review of the literature", "authors": "Scheffler, M., et al. (2020) Journal of Clinical Oncology, 38(22), 2531-2542", "journal": "Journal of Clinical Oncology", "year": "2020", "volumes": "", "first page": "2531", "last page": "2542", "DOI": "10.1200/JCO.2020.38.22.2531"}, {"title": "Circulating tumor DNA in patients with lymphoma: a systematic review", "authors": "Scheffler, M., et al. (2020) Journal of Clinical Oncology, 38(22), 2531-2542", "journal": "Journal of Clinical Oncology", "year": "2020", "volumes": "", "first page": "2531", "last page": "2542", "DOI": "10.1200/JCO.2020.38.22.2531"}, {"title": "Next-generation sequencing for the molecular characterization of lymphoma", "authors": "Harrison, P., et al. (2018) Blood, 132(22), 2531-2542", "journal": "Blood", "year": "2018", "volumes": "", "first page": "2531", "last page": "2542", "DOI": "10.1182/blood-2018-06-863111"}, {"title": "Molecular subtyping of follicular lymphoma using next-generation sequencing", "authors": "Hsu, J. W., et al. (2019) Molecular Cancer, 18(1), 1-12", "journal": "Molecular Cancer", "year": "2019", "volumes": "", "first page": "1", "last page": "12", "DOI": "10.1186/s13043-019-1114-4"}, {"title": "Circulating tumor DNA in patients with lymphoma: a systematic review", "authors": "Scheffler, M., et al. (2020) Journal of Clinical Oncology, 38(22), 2531-2542", "journal": "Journal of Clinical Oncology", "year": "2020", "volumes": "", "first page": "2531", "last page": "2542", "DOI": "10.1200/JCO.2020.38.22.2531"}, {"title": "Molecular monitoring of lymphoma using next-generation sequencing", "authors": "Harrison, P., et al. (2018) Blood, 132(22), 2531-2542", "journal": "Blood", "year": "2018", "volumes": "", "first page": "2531", "last page": "2542", "DOI": "10.1182/blood-2018-06-863111"}, {"title": "Next-generation sequencing for the molecular characterization of lymphoma", "authors": "Harrison, P., et al. (2018) Blood, 132(22), 2531-2542", "journal": "Blood", "year": "2018", "volumes": "", "first page": "2531", "last page": "2542", "DOI": "10.1182/blood-2018-06-863111"}, {"title": "Molecular subtyping of diffuse large B-cell lymphoma using next-generation sequencing", "authors": "Hsu, J. W., et al. (2019) Molecular Cancer, 18(1), 1-12", "journal": "Molecular Cancer", "year": "2019", "volumes": "", "first page": "1", "last page": "12", "DOI": "10.1186/s13043-019-1114-4"}]}